EFFECT OF DIFFERENT RENAL GLUTATHIONE LEVELS ON RENAL MERCURY DISPOSITION AND EXCRETION IN THE RAT

被引:20
作者
GIRARDI, G [1 ]
ELIAS, MM [1 ]
机构
[1] UNIV NACL ROSARIO,FAC CIENCIAS BIOQUIM & FARMACEUT,CONSEJO NACL INVEST CIENT & TECN,RA-2000 ROSARIO,ARGENTINA
关键词
MERCURY NEPHROTOXICITY; RENAL MERCURY DISPOSITION; NONPROTEIN SULFHYDRYLS; RENAL MERCURY EXCRETION;
D O I
10.1016/0300-483X(93)90156-M
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mercury renal disposition has been studied following HgCl2 injection (5.0 mg/kg body wt., s.c.) in controls, diethylmaleate and N-acetylcysteine-treated rats. The different treatments were used to generate statistically different degrees of non-protein sulfhydryls concentration in kidneys. Diethylmaleate (4 mmol/kg body wt., i.p.) diminished kidney glutathione levels to 25% and N-acetylcysteine (2 mmol/kg body wt., i.p.) increased kidney non-protein sulfhydryls levels up to 75% compared with new controls. The amount of mercury in the kidneys, the mercury excretion rate in urine and the mercury plasma disappearance curves were calculated during 3 h post HgCl2 injection. BUN was measured in plasma at the same time period to determine the onset of kidney damage. The results indicate a higher HgCl2 renal clearance in N-acetylcysteine-treated rats compared to controls and less renal mercury accumulation. The data agree with diminished renal toxicity. On the other hand, renal mercury accumulation was higher and mercury renal clearance lower in diethylmaleate-treated animals, associated with higher renal toxicity. The results suggest that non-protein sulfhydryl levels (principally glutathione) might determine renal accumulation of mercury as well as its elimination rate and hence might enhance or mitigate the nephrotoxicity induced by the metal.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 35 条
[1]   PENICILLAMINE AND ANALOGOUS CHELATING AGENTS [J].
APOSHIAN, HV .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :481-&
[2]   THE EFFECT OF DEPLETION OF NONPROTEIN SULFHYDRYLS BY DIETHYL MALEATE PLUS BUTHIONINE SULFOXIMINE ON RENAL UPTAKE OF MERCURY IN THE RAT [J].
BAGGETT, JM ;
BERNDT, WO .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 83 (03) :556-562
[3]  
BALLATORI N, 1984, BIOCHEM PHARMACOL, V33, P1093, DOI 10.1016/0006-2952(84)90519-7
[4]   UPTAKE AND RETENTION OF MERCURY IN MOUSE BRAIN - A COMPARISON OF EXPOSURE TO MERCURY VAPOR AND INTRAVENOUS INJECTION OF MERCURIC SALT [J].
BERLIN, M ;
JERKSELL, LG ;
VONUBISC.H .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1966, 12 (01) :33-&
[5]   RENAL GLUTATHIONE AND MERCURY UPTAKE BY KIDNEY [J].
BERNDT, WO ;
BAGGETT, JM ;
BLACKER, A ;
HOUSER, M .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (05) :832-839
[6]   THE RELATIONSHIP BETWEEN GAMMA-GLUTAMYL TRANSPEPTIDASE AND HG LEVELS IN SE/HG ANTAGONISM IN MOUSE-LIVER AND KIDNEY [J].
DISIMPLICIO, P ;
GORELLI, M ;
CIUFFREDA, P ;
LEONZIO, C .
PHARMACOLOGICAL RESEARCH, 1990, 22 (04) :515-526
[7]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[8]   MECHANISMS OF ABSORPTION OF INORGANIC MERCURY FROM RAT SMALL-INTESTINE .4. EFFECT OF CHELATING-AGENTS AND CYSTEINE ON ABSORPTION OF MERCURIC-CHLORIDE INSITU AND INVITRO [J].
ENDO, T ;
NAKAYA, S ;
KIMURA, R .
PHARMACOLOGY & TOXICOLOGY, 1991, 68 (03) :171-176
[9]   EFFECTIVENESS OF N-ACETYLCYSTEINE IN PROTECTING AGAINST MERCURIC CHLORIDE-INDUCED NEPHROTOXICITY [J].
GIRARDI, G ;
ELIAS, MM .
TOXICOLOGY, 1991, 67 (02) :155-164
[10]  
GIRARDI G, 1989, Toxicology, V58, P187